Emet Surgical, Inc.
Emet Surgical, founded by a cancer survivor, aims to improve surgical outcomes through innovative tools that enhance collaboration between surgeons and pathologists. Their mission is to develop easy-to-use, regulatory-approved solutions like TrueMargin™ and TrueGastro™ that provide precise tumor margin and tissue recognition, reducing reoperations and improving patient care. Headquartered in Denver with operations in Israel, the company is advancing minimally invasive surgery with augmented intelligence and is actively seeking FDA clearance and international registrations.
Industries
Nr. of Employees
small (1-50)
Emet Surgical, Inc.
1660 S Albion Street, Suite 315, Denver, Colorado 80222 USA
Products
Augmented intraoperative video guidance system (investigational)
System that analyzes live minimally invasive surgical video and overlays anatomical maps and visual guidance on the surgeon's monitor to support dissection and margin assessment.
Tumor margin marking system (investigational)
Surgical marking tools and method that provide correlated in‑vivo and ex‑vivo location and orientation information intended to improve communication between surgical and pathology teams.
Minimally invasive colon marking method (investigational)
Highly visible colon marking approach intended for surveillance and minimally invasive colorectal surgeries to replace older marking methods.
Augmented intraoperative video guidance system (investigational)
System that analyzes live minimally invasive surgical video and overlays anatomical maps and visual guidance on the surgeon's monitor to support dissection and margin assessment.
Tumor margin marking system (investigational)
Surgical marking tools and method that provide correlated in‑vivo and ex‑vivo location and orientation information intended to improve communication between surgical and pathology teams.
Minimally invasive colon marking method (investigational)
Highly visible colon marking approach intended for surveillance and minimally invasive colorectal surgeries to replace older marking methods.
Services
Design, engineering, prototyping, production planning and coordination with contract manufacturers to move devices toward volume production.
Development of a custom QMS and preparation of regulatory submission packages intended for FDA 510(k) and other country registrations.
Planning of post-approval studies to measure device effectiveness in improving surgeon–pathologist communication and surgical outcomes.
Design, engineering, prototyping, production planning and coordination with contract manufacturers to move devices toward volume production.
Development of a custom QMS and preparation of regulatory submission packages intended for FDA 510(k) and other country registrations.
Planning of post-approval studies to measure device effectiveness in improving surgeon–pathologist communication and surgical outcomes.
Expertise Areas
- Digital surgical guidance systems
- Computer vision and machine learning for intraoperative video
- Surgical–pathology communication and specimen orientation
- Medical device design for open, minimally invasive, and robotic procedures
Key Technologies
- Real-time surgical video processing
- Computer vision-based image segmentation
- Machine learning tissue classification
- Augmented reality overlays for surgical displays
News & Updates
The company showcased its tumor marking and mapping tools, including TrueMargin™ and TrueGastro™, aiming to improve communication and reduce reoperations.
The article discusses the company's efforts to enhance communication between surgeons and pathologists to reduce incomplete tumor excisions and re-surgeries.
The company showcased its tumor marking and mapping tools, including TrueMargin™ and TrueGastro™, aiming to improve communication and reduce reoperations.
The article discusses the company's efforts to enhance communication between surgeons and pathologists to reduce incomplete tumor excisions and re-surgeries.